Associate Professor
Dept of Clinical Pharmacy

MEMPHIS TN 381632198
Tel: (901) 448-1438


  • None, University of Tennessee, Critical care pharmacy fellowship
  • None, University of Tennessee/The Med, Critical care pharmacy residency
  • Pharm.D., University of Tennessee, Pharmacy

Clinical Care Specialty/Interest

I practice as a clinical pharmacist with the trauma ICU service at the Med. 

Research Interest/Specialty

Critical care

Infectious diseases


Ventilator-associated pneumonia

Pharmacogenomics, pharmacokinetics


  1. Wood, GC, Boucher, AB, Johnson, JL, Wisniewski, JN, Magnotti, LJ, Croce, MA, Swanson, JM, Boucher, BA, Fabian, TC. Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series. Pharmacotherapy, 34 (1), 89-93, 2014.
  2. Monteen, MR, Ponnapula, S, Wood, GC, Croce, MA, Swanson, JM, Boucher, BA, Fabian, TC. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient. Ann Pharmacother, 47 (12), 1736-9, 2013.
  3. Ponnapula, S, Swanson, JM, Wood, GC, Boucher, BA, Wells, DL, Croce, MA, Fabian, TC. Treatment of Rhizobium radiobacter bacteremia in a critically ill trauma patient. Ann Pharmacother, 47 (11), 1584-7, 2013.
  4. Swanson, JM, Wood, GC, Xu, L, Tang, LE, Meibohm, B, Homayouni, R, Croce, MA, Fabian, TC. Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: a pilot study. PLoS One, 7 (8), e42065, 2012.
  5. Wood, GC. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Expert Rev Anti Infect Ther, 9 (11), 993-1000, 2011.
  6. Magnotti, LJ, Croce, MA, Zarzaur, BL, Swanson, JM, Wood, GC, Weinberg, JA, Fabian, TC. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients. J Am Coll Surg, 212 (4), 476-84; discussion 484-6, 2011.
  7. Wood, GC, Underwood, EL, Croce, MA, Swanson, JM, Fabian, TC. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin. Ann Pharmacother, 44 (10), 1665-8, 2010.
  8. Swanson, JM, Mueller, EW, Croce, MA, Wood, GC, Boucher, BA, Magnotti, LJ, Fabian, TC. Changes in pulmonary cytokines during antibiotic therapy for ventilator-associated pneumonia. Surg Infect (Larchmt), 11 (2), 161-7, 2010.
  9. Wood, GC, Swanson, JM. Managing ventilator-associated pneumonia. AACN Adv Crit Care, 20 (4), 309-16; quiz 317-8, 2009.
  10. Swanson, JM, Wood, GC, Croce, MA, Mueller, EW, Boucher, BA, Fabian, TC. Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia. J Trauma, 65 (6), 1271-7, 2008.
  11. Wood, GC, Swanson, JM. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia. Drugs, 67 (6), 903-14, 2007.
  12. Boucher, BA, Wood, GC, Swanson, JM. Pharmacokinetic changes in critical illness. Crit Care Clin, 22 (2), 255-71, vi, 2006.
  13. Wood, GC, Mueller, EW, Croce, MA, Boucher, BA, Fabian, TC. Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients. Intensive Care Med, 32 (4), 599-603, 2006.
  14. Croce, MA, Swanson, JM, Magnotti, LJ, Claridge, JA, Weinberg, JA, Wood, GC, Boucher, BA, Fabian, TC. The futility of the clinical pulmonary infection score in trauma patients. J Trauma, 60 (3), 523-7; discussion 527-8, 2006.